Observational studyBMJ open respiratory research2026
Respiratory oscillometry identifies disease progression in interstitial lung disease.
Observational study in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- It's not all about small airways disease: key limitations of oscillometry interpretation.Frontiers in allergy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRespiratory oscillometry is an effort-independent method of evaluating lung function. Its role in the monitoring of interstitial lung disease (ILD) is unclear. This observational longitudinal study assessed the relationship between oscillometry and pulmonary function test (PFT) parameters in ILD over time and determined whether oscillometry can detect disease progression.
methodsParticipants underwent PFT and oscillometry within the same visit at two time points. Oscillometry parameters of interest included resistance at 5 Hz (R
resultsOf the 43 participants enrolled, 17 (40%) demonstrated interval clinical worsening over a median follow-up of 384 days. Spirometry parameters displayed moderate-to-strong correlations with all oscillometry parameters, especially the reactance measures AX and X
conclusionReactance measures of oscillometry remained correlated with traditional lung function tests over time. Oscillometry parameters also showed significant temporal differences between participants with and without evidence of clinical worsening, unlike spirometry measures, which did not capture progression. These findings suggest that oscillometry may hold value in the longitudinal monitoring of ILD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.